Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel

BACKGROUND: Pancreatic cancer is associated with a high thromboembolism risk. We investigated the significance of early venous thromboembolism (VTE) detection in patients with unresectable metastatic pancreatic cancer (UR-MPC) who received first-line chemotherapy with gemcitabine plus nab-paclitaxel...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamai, Takuo, Ikezawa, Kenji, Hiraga, Erika, Kawamoto, Yasuharu, Hirao, Takeru, Higashi, Sena, Daiku, Kazuma, Maeda, Shingo, Abe, Yutaro, Urabe, Makiko, Kai, Yugo, Takada, Ryoji, Nakabori, Tasuku, Fukutake, Nobuyasu, Uehara, Hiroyuki, Fujita, Masashi, Ohkawa, Kazuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887762/
https://www.ncbi.nlm.nih.gov/pubmed/35231078
http://dx.doi.org/10.1371/journal.pone.0264653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887762/
https://www.ncbi.nlm.nih.gov/pubmed/35231078
http://dx.doi.org/10.1371/journal.pone.0264653

Ejemplares similares